Company / Net Debt per Share
Royalty Pharma plc Net Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$13.82
FY2025
5-year range
$13.64 / $15.26
FY2021-FY2025
Trend
-9.4%
vs FY2024
Sector context
#13 of 82
Health Care
What the data says
Royalty Pharma plc's net debt per share of $13.82 is higher than 84% of companies in the Health Care sector (FY2025). Net Debt per Share has fluctuated over the past 6 years, ranging from $12.81 in FY2020 to $15.26 in FY2024.
Based on SEC 10-K filings.
13.82 in FY2025 with a 5-year CAGR of +1.5%. Top quartile in the Health Care sector.
Remained stable around $13.82 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -1.4%
- 5-Year CAGR
- +1.5%
- 10-Year CAGR
- -
Sector benchmark
+1122.8% above sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 9.4% year-over-year.
- Ranks #13 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2024.
- Lowest net debt per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.82 | -9.4% |
| FY2024 | $15.26 | +11.9% |
| FY2023 | $13.64 | -5.3% |
| FY2022 | $14.40 | -2.7% |
| FY2021 | $14.80 | +15.5% |
| FY2020 | $12.81 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026